drugset / Trial / NCT03052972

Flortaucipir 18F PET Imaging in BIOCARD Study

NCT03052972

Phase 1 Terminated 23 enrolled Avid Radiopharmaceuticals
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

This study is designed to assess the imaging characteristics of Flortaucipir (18F-AV-1451) in subjects who participated in the Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD) study at Johns Hopkins University.

Timeline

Start
2017-03-23
Primary completion
2018-08-14
Completion
2018-08-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Flortaucipir F18 Diagnostic / imaging agent 370 mbq

Indications